Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2025.11.25
PROXY FORM
2025.11.25
NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING
2025.11.25
Circulars
2025.11.24
(1) PROPOSED ABOLITION OF THE SUPERVISORY COMMITTEE AND THE PROPOSED AMENDMENTS ...
2025.10.30
2025 THIRD QUARTERLY REPORT
2025.10.17
Pls arrange upload
2025.09.18
2025 INTERIM REPORT
2025.08.29
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025
2025.08.15
DATE OF BOARD MEETING
2025.07.18
VOLUNTARY ANNOUNCEMENT H1710 INJECTION HAS ENROLLED THE FIRST SUBJECT AND COMPLE...
第一页
上一页
1
2
3
4
5
下一页
最后一页
